REVIVE: Rusfertide Effective for Erythrocytosis Control in Polycythemia Vera; Rusfertide maintained a hematocrit of <45% and reduced or eliminated the use of phlebotomy in patients with polycythemia vera.

Press/Media

Period21 Feb 2024

Media coverage

2

Media coverage

  • TitleREVIVE: Rusfertide Effective for Erythrocytosis Control in Polycythemia Vera; Rusfertide maintained a hematocrit of
    Media name/outletConsultant Live
    Country/TerritoryUnited States
    Date21/02/24
    PersonsMarina Kremyanskaya
  • TitleREVIVE: Rusfertide Effective for Erythrocytosis Control in Polycythemia Vera
    Media name/outletHCP Live
    Country/TerritoryUnited States
    Date21/02/24
    PersonsMarina Kremyanskaya